Go Pro

PhenixFIN (PFX) Financials

PhenixFIN logo
$46.14 -0.01 (-0.02%)
As of 02:05 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for PhenixFIN

Annual Income Statements for PhenixFIN

This table shows PhenixFIN's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders
13 6.58 -10 22 -16
Consolidated Net Income / (Loss)
13 6.58 -10 22 -16
Net Income / (Loss) Continuing Operations
13 6.58 -10 22 -16
Total Pre-Tax Income
13 6.58 -10 22 -16
Total Revenue
56 24 17 57 24
Net Interest Income / (Expense)
32 20 13 15 18
Total Interest Income
32 25 13 15 18
Investment Securities Interest Income
32 25 12 15 18
Deposits and Money Market Investments Interest Income
0.01 0.14 0.40 0.50 0.19
Total Interest Expense
0.00 5.11 0.00 0.00 0.00
Total Non-Interest Income
24 4.66 3.98 42 6.56
Other Service Charges
0.08 0.32 0.40 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments
-16 4.34 -17 19 -19
Investment Banking Income
32 - 20 22 25
Total Non-Interest Expense
37 18 22 28 30
Salaries and Employee Benefits
1.99 2.95 4.19 6.85 5.07
Other Operating Expenses
35 15 18 21 25
Nonoperating Income / (Expense), net
-5.80 - -5.53 -6.61 -10
Basic Earnings per Share
- ($2.63) $12.87 $9.13 $2.06
Weighted Average Basic Shares Outstanding
2.68M 2.32M 2.09M 2.04M 2.02M
Diluted Earnings per Share
- ($2.63) $12.87 $9.13 $2.06
Weighted Average Diluted Shares Outstanding
- 2.32M 2.09M 2.04M 2.02M
Weighted Average Basic & Diluted Shares Outstanding
- - 2.07M 2.02M 2.00M

Quarterly Income Statements for PhenixFIN

This table shows PhenixFIN's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
3.57 -3.52 22 -14 5.08 -1.30 -21 1.70 5.21 -0.27 5.24
Consolidated Net Income / (Loss)
3.57 -3.52 22 -12 5.08 -1.30 -21 1.70 5.21 -0.27 5.24
Net Income / (Loss) Continuing Operations
3.57 -3.52 22 -14 5.08 -1.30 -21 1.70 5.21 -0.27 5.24
Total Pre-Tax Income
3.57 -3.52 22 -14 5.08 -1.30 -21 1.70 5.21 -0.27 5.24
Total Revenue
12 4.66 30 6.24 14 8.80 -11 13 14 5.97 14
Net Interest Income / (Expense)
3.71 3.01 4.72 14 4.01 3.92 5.29 4.58 4.11 7.07 4.64
Total Interest Income
3.71 3.01 4.72 20 4.01 3.92 5.29 4.58 4.11 9.38 4.64
Investment Securities Interest Income
3.67 2.81 4.57 20 3.78 3.88 5.26 4.68 4.06 9.33 4.61
Deposits and Money Market Investments Interest Income
0.04 0.20 0.15 0.11 0.23 0.05 0.03 -0.11 0.06 0.05 0.03
Total Interest Expense
0.00 0.00 0.00 6.61 0.00 0.00 0.00 - 0.00 2.31 0.00
Total Non-Interest Income
7.89 1.65 26 -7.52 10 4.88 -17 8.08 10 -1.10 9.35
Net Realized & Unrealized Capital Gains on Investments
2.17 -3.01 19 12 3.96 -1.16 -23 1.31 3.50 -1.10 2.90
Investment Banking Income
5.72 4.66 6.23 - 6.22 6.02 6.16 6.87 6.66 - 6.45
Total Non-Interest Expense
6.48 6.61 6.79 26 6.64 7.53 7.34 8.46 6.63 6.24 6.43
Salaries and Employee Benefits
1.42 1.52 1.51 2.39 1.03 1.19 1.24 1.62 0.97 1.02 1.08
Other Operating Expenses
5.06 5.08 5.27 23 5.61 6.34 6.10 6.85 5.67 5.22 5.35
Nonoperating Income / (Expense), net
-1.54 -1.57 -1.72 - -2.55 -2.58 -2.66 -2.49 -2.43 - -2.32
Basic Earnings per Share
$2.19 $2.62 $1.29 - $1.22 ($0.44) ($0.74) $2.02 ($2.38) $0.57 $2.19
Weighted Average Basic Shares Outstanding
2.07M 2.05M 2.02M 2.04M 2.02M 2.02M 2.02M 2.02M 2.00M 1.97M 1.93M
Diluted Earnings per Share
$2.19 $2.62 $1.29 - $1.22 ($0.44) ($0.74) $2.02 ($2.38) $0.57 $2.19
Weighted Average Diluted Shares Outstanding
2.07M 2.05M 2.02M 2.04M 2.02M 2.02M 2.02M 2.02M 2.00M 1.97M 1.93M
Weighted Average Basic & Diluted Shares Outstanding
2.06M 2.02M 2.02M 2.02M 2.02M 2.02M 2.00M 2.00M 2.00M 1.93M 1.93M

Annual Cash Flow Statements for PhenixFIN

This table details how cash moves in and out of PhenixFIN's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Net Change in Cash & Equivalents
13 -47 -17 62 -60
Net Cash From Operating Activities
95 -29 -21 16 -67
Net Cash From Continuing Operating Activities
94 -29 -21 16 -67
Net Income / (Loss) Continuing Operations
0.00 -6.11 27 19 4.16
Consolidated Net Income / (Loss)
- -6.11 27 19 4.16
Amortization Expense
0.32 0.15 -0.90 0.52 0.31
Non-Cash Adjustments to Reconcile Net Income
121 -41 -32 -1.95 -74
Changes in Operating Assets and Liabilities, net
-27 17 -15 -1.09 2.29
Net Cash From Investing Activities
0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
-82 -17 3.93 45 7.05
Net Cash From Continuing Financing Activities
-82 -17 3.93 45 7.05
Issuance of Debt
0.00 58 36 76 55
Repayment of Debt
-74 -55 -31 -25 -44
Repurchase of Common Equity
-8.20 -17 -1.06 -2.37 -0.80
Payment of Dividends
0.00 -0.27 0.00 -2.65 -2.89
Other Financing Activities, Net
0.00 -2.31 -0.94 -0.80 -1.18
Cash Interest Paid
6.60 4.24 4.65 5.53 8.76

Quarterly Cash Flow Statements for PhenixFIN

This table details how cash moves in and out of PhenixFIN's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
6.19 6.95 -10 59 -60 1.50 -1.42 0.02 -3.88 -0.33 -0.90
Net Cash From Operating Activities
6.75 8.96 -8.32 8.71 -66 8.79 -6.88 -2.97 -2.04 2.71 -0.69
Net Cash From Continuing Operating Activities
6.75 8.96 -8.32 8.71 -66 8.79 -6.72 -2.80 -2.04 2.71 -0.69
Net Income / (Loss) Continuing Operations
4.53 5.37 2.61 6.10 2.46 -0.90 -1.50 4.08 -4.77 1.13 4.22
Consolidated Net Income / (Loss)
4.53 5.37 2.61 6.10 2.46 -0.90 -1.50 4.08 -4.77 1.13 4.22
Amortization Expense
-0.28 0.39 0.12 0.30 0.22 0.23 -0.04 -0.10 0.05 -0.26 -0.18
Non-Cash Adjustments to Reconcile Net Income
4.70 1.99 -14 4.67 -72 14 -7.36 -7.91 7.24 0.28 -5.43
Changes in Operating Assets and Liabilities, net
-2.19 1.21 2.49 -2.37 3.17 -4.19 2.19 1.12 -4.55 1.57 0.69
Net Cash From Financing Activities
-0.57 -2.01 -1.94 50 5.88 -7.29 5.46 2.99 -1.84 -3.04 -0.20
Net Cash From Continuing Financing Activities
-0.57 -2.01 -1.94 50 5.88 -7.29 5.46 2.99 -1.84 -3.04 -0.20
Repurchase of Common Equity
-0.54 -1.80 -0.03 - 0.00 - -0.80 -0.00 -0.18 -3.14 -0.03
Payment of Dividends
- - -2.65 - - - - - - - -0.14
Other Financing Activities, Net
-0.03 -0.21 -0.05 -0.51 -0.04 0.00 -1.14 -0.00 0.00 - -0.03
Cash Interest Paid
1.32 1.35 1.70 1.17 1.98 2.22 2.22 2.34 2.29 2.18 2.16

Annual Balance Sheets for PhenixFIN

This table presents PhenixFIN's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 9/30/2022 9/30/2023 9/30/2024 9/30/2025
Total Assets
219 240 303 317
Cash and Due from Banks
23 5.99 68 7.29
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00
Customer and Other Receivables
0.27 0.41 0.09 0.57
Deferred Acquisition Cost
0.05 0.70 0.76 1.38
Other Assets
2.83 233 234 308
Total Liabilities & Shareholders' Equity
219 240 303 317
Total Liabilities
98 93 142 156
Accrued Interest Payable
0.50 0.69 0.77 1.19
Long-Term Debt
78 0.00 0.09 148
Other Long-Term Liabilities
20 8.04 5.86 6.80
Commitments & Contingencies
0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
121 147 160 161
Total Preferred & Common Equity
121 147 160 161
Total Common Equity
121 147 160 161
Common Stock
675 695 705 705
Retained Earnings
-555 -548 -545 -544

Quarterly Balance Sheets for PhenixFIN

This table presents PhenixFIN's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 12/31/2024 3/31/2025 6/30/2025 12/31/2025 3/31/2026 6/30/2026
Total Assets
238 248 246 312 301 307 307 306 310
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Customer and Other Receivables
0.42 - - 1.04 0.26 1.10 0.30 0.28 0.26
Deferred Acquisition Cost
0.64 0.72 0.65 0.63 0.42 1.46 1.31 1.23 1.19
Other Assets
2.39 442 236 303 291 297 302 301 306
Total Liabilities & Shareholders' Equity
238 248 246 312 301 307 307 306 310
Total Liabilities
87 93 92 149 142 150 152 152 152
Short-Term Debt
- 0.10 - 142 137 - 147 147 0.10
Accrued Interest Payable
0.72 0.72 0.52 1.03 1.08 1.21 1.16 1.13 1.12
Long-Term Debt
84 84 85 0.05 0.05 145 0.13 0.13 147
Other Long-Term Liabilities
2.08 8.10 6.10 6.34 3.16 3.83 3.72 3.88 3.97
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
151 154 154 163 159 157 156 154 158
Total Preferred & Common Equity
151 154 154 163 159 157 156 154 158
Total Common Equity
151 154 154 163 159 157 156 154 158
Common Stock
694 692 692 705 705 704 704 701 701
Retained Earnings
-544 -538 -538 -542 -546 -547 -549 -548 -543

Annual Metrics And Ratios for PhenixFIN

This table displays calculated financial ratios and metrics derived from PhenixFIN's official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 9/30/2021 9/30/2022 9/30/2023 9/30/2024 9/30/2025
DEI Shares Outstanding
0.00 0.00 2,088,589.00 - 2,060,490.00
DEI Adjusted Shares Outstanding
0.00 0.00 2,088,589.00 - 2,060,490.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -4.98 - -7.71
Growth Metrics
- - - - -
Revenue Growth
0.00% -56.29% -30.90% 102.45% -57.13%
EBITDA Growth
0.00% -65.38% -185.63% 261.51% -118.24%
EBIT Growth
0.00% -65.58% -173.84% 227.67% -119.65%
NOPAT Growth
0.00% -65.58% -151.69% 227.67% -113.76%
Net Income Growth
0.00% -50.59% -257.89% 227.67% -172.46%
EPS Growth
0.00% 0.00% 589.35% -29.06% -77.44%
Operating Cash Flow Growth
0.00% -130.80% 29.33% 177.78% -518.06%
Free Cash Flow Firm Growth
0.00% 0.00% 81.50% -35.78% 54.34%
Invested Capital Growth
0.00% 0.00% 16.17% 28.21% 4.32%
Revenue Q/Q Growth
0.00% 0.00% -68.21% -38.81% -15.10%
EBITDA Q/Q Growth
0.00% 0.00% -110.93% -70.22% -677.19%
EBIT Q/Q Growth
0.00% 0.00% -109.22% -70.79% -2,747.34%
NOPAT Q/Q Growth
0.00% 0.00% -105.41% -68.87% -104.48%
Net Income Q/Q Growth
0.00% 0.00% -120.81% -67.12% -479.32%
EPS Q/Q Growth
0.00% 0.00% -58.95% 0.00% -32.90%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -52.29% 453.51% -21.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -127.77% 73.94%
Invested Capital Q/Q Growth
0.00% 0.00% 3.15% 23.64% 2.37%
Profitability Metrics
- - - - -
EBITDA Margin
34.84% 27.60% -34.20% 58.59% -21.76%
EBIT Margin
34.27% 26.99% -28.84% 57.76% -23.02%
Profit (Net Income) Margin
23.88% 26.99% -61.66% 57.76% -65.22%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
69.67% 100.00% 213.82% 100.00% 283.31%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 6.62% -1.58% 13.94% -1.30%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 6.62% -10.20% 13.94% -9.72%
Return on Net Nonoperating Assets (RNNOA)
0.00% 4.27% -6.18% 9.99% -8.60%
Return on Equity (ROE)
0.00% 10.89% -7.77% 23.92% -9.90%
Cash Return on Invested Capital (CROIC)
0.00% -193.38% -16.55% -10.79% -5.53%
Operating Return on Assets (OROA)
0.00% 3.01% -2.12% 13.54% -1.81%
Return on Assets (ROA)
0.00% 3.01% -4.53% 13.54% -5.13%
Return on Common Equity (ROCE)
0.00% 10.89% -7.77% 23.92% -9.90%
Return on Equity Simple (ROE_SIMPLE)
0.00% 5.45% -7.08% 22.91% -9.88%
Net Operating Profit after Tax (NOPAT)
19 6.58 -3.40 37 -3.93
NOPAT Margin
34.27% 26.99% -20.19% 57.76% -16.11%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 8.62% 0.00% 8.42%
SG&A Expenses to Revenue
3.57% 12.11% 24.84% 10.78% 20.80%
Operating Expenses to Revenue
65.73% 73.01% 128.84% 42.24% 123.02%
Earnings before Interest and Taxes (EBIT)
19 6.58 -4.86 37 -5.61
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
19 6.73 -5.76 37 -5.30
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.65 0.51 0.61 0.60
Price to Tangible Book Value (P/TBV)
0.00 0.65 0.51 0.61 0.60
Price to Revenue (P/Rev)
0.00 3.23 4.44 1.53 3.94
Price to Earnings (P/E)
0.00 11.97 0.00 2.64 0.00
Dividend Yield
0.00% 0.35% 0.00% 2.75% 5.75%
Earnings Yield
0.00% 8.35% 0.00% 37.81% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.67 0.66 0.56 0.79
Enterprise Value to Revenue (EV/Rev)
0.00 5.49 9.09 2.60 10.02
Enterprise Value to EBITDA (EV/EBITDA)
0.00 19.91 0.00 4.44 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 20.36 0.00 4.50 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 20.36 0.00 4.50 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 10.27 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.00 0.65 0.57 0.85 0.92
Long-Term Debt to Equity
0.00 0.65 0.00 0.00 0.00
Financial Leverage
0.00 0.65 0.61 0.72 0.88
Leverage Ratio
0.00 1.81 1.71 1.77 1.93
Compound Leverage Factor
0.00 1.81 3.66 1.77 5.47
Debt to Total Capital
0.00% 39.22% 36.48% 45.86% 47.96%
Short-Term Debt to Total Capital
0.00% 0.00% 36.48% 45.83% 47.91%
Long-Term Debt to Total Capital
0.00% 39.22% 0.00% 0.03% 0.04%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 60.79% 63.52% 54.14% 52.04%
Debt to EBITDA
0.00 11.58 -14.62 3.65 -27.94
Net Debt to EBITDA
0.00 8.20 -13.58 1.83 -27.94
Long-Term Debt to EBITDA
0.00 11.58 0.00 0.00 -0.03
Debt to NOPAT
0.00 11.85 -24.77 3.70 -37.74
Net Debt to NOPAT
0.00 8.39 -23.01 1.86 -37.74
Long-Term Debt to NOPAT
0.00 11.85 0.00 0.00 -0.03
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - -
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -192 -36 -28 -17
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -37.59 0.00 -4.30 0.00
Operating Cash Flow to Interest Expense
0.00 -5.73 0.00 2.44 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 -5.73 0.00 2.44 0.00
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.11 0.07 0.23 0.08
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - -
Invested Capital
0.00 199 231 296 309
Invested Capital Turnover
0.00 0.25 0.08 0.24 0.08
Increase / (Decrease) in Invested Capital
0.00 199 32 65 13
Enterprise Value (EV)
0.00 134 153 165 244
Market Capitalization
0.00 79 75 97 96
Book Value per Share
$0.00 $52.01 $70.24 $78.57 $79.78
Tangible Book Value per Share
$0.00 $52.01 $70.24 $78.57 $79.78
Total Capital
0.00 199 231 296 309
Total Debt
0.00 78 84 136 148
Total Long-Term Debt
0.00 78 0.00 0.09 0.13
Net Debt
0.00 55 78 68 148
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
5.80 0.00 6.99 0.00 12
Net Nonoperating Obligations (NNO)
0.00 78 84 136 148
Total Depreciation and Amortization (D&A)
0.32 0.15 -0.90 0.52 0.31
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $9.13 $2.06
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 2.09M 2.04M 2.02M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $9.13 $2.06
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 2.07M 2.04M 2.02M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 2.07M 2.02M 2.00M
Normalized Net Operating Profit after Tax (NOPAT)
13 4.81 -3.40 26 -3.93
Normalized NOPAT Margin
23.99% 19.74% -20.19% 40.43% -16.11%
Pre Tax Income Margin
23.88% 26.99% -61.66% 57.76% -65.22%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
0.00 1.29 0.00 5.56 0.00
NOPAT to Interest Expense
0.00 1.29 0.00 5.56 0.00
EBIT Less CapEx to Interest Expense
0.00 1.29 0.00 5.56 0.00
NOPAT Less CapEx to Interest Expense
0.00 1.29 0.00 5.56 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 4.04% 0.00% 7.20% -18.18%
Augmented Payout Ratio
61.58% 261.79% -10.18% 13.66% -23.22%

Quarterly Metrics And Ratios for PhenixFIN

This table displays calculated financial ratios and metrics derived from PhenixFIN's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
2,088,589.00 2,060,490.00 2,060,490.00 - - 2,060,490.00 2,060,490.00 2,060,490.00 2,060,490.00 2,060,490.00 1,932,600.00
DEI Adjusted Shares Outstanding
2,088,589.00 2,060,490.00 2,060,490.00 - - 2,060,490.00 2,060,490.00 2,060,490.00 2,060,490.00 2,060,490.00 1,932,600.00
DEI Earnings Per Adjusted Shares Outstanding
1.71 -1.71 10.59 - - -0.63 -10.37 0.83 2.53 -0.13 2.71
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-35.46% -80.52% 210.21% 130.80% 22.93% 89.10% -137.47% 23.74% 13.84% -32.23% 223.07%
EBITDA Growth
-75.31% -105.07% 354.76% 58.10% 62.23% 196.29% -179.22% 92.72% 18.28% -135.67% 139.37%
EBIT Growth
-73.83% -106.31% 355.21% 56.59% 49.01% 165.37% -179.44% 129.96% 21.65% -121.48% 140.40%
NOPAT Growth
-73.83% -104.42% 355.21% 65.43% 49.01% 165.37% -155.61% 129.96% 21.65% -121.48% 157.71%
Net Income Growth
-80.49% -111.91% 144.74% 73.87% 42.07% 62.99% -197.90% 3,506.37% -17.08% 78.96% 124.51%
EPS Growth
0.00% 0.00% 0.00% 0.00% -44.29% -116.79% -157.36% -33.33% -295.08% 229.55% 395.95%
Operating Cash Flow Growth
243.80% 232.71% -74.25% 294.30% -1,081.14% -1.88% 17.36% -134.13% 96.92% -69.15% 89.91%
Free Cash Flow Firm Growth
-0.08% -8.76% 103.64% -22.56% 41.17% 47.91% -1,046.59% 86.42% 115.34% 92.45% 106.00%
Invested Capital Growth
88.49% 82.07% 6.96% 28.21% 29.58% 24.15% 26.00% 4.32% -0.68% 1.38% 1.00%
Revenue Q/Q Growth
157.29% -59.86% 551.56% -52.42% 128.64% -29.79% -229.09% 211.41% 12.74% -58.20% 134.42%
EBITDA Q/Q Growth
110.66% -132.37% 1,612.64% -371.23% 141.29% -76.82% -1,344.53% 121.86% 87.54% -106.99% 1,473.46%
EBIT Q/Q Growth
111.51% -138.17% 1,305.96% -380.24% 139.51% -79.68% -1,565.44% 122.45% 81.99% -103.59% 2,856.18%
NOPAT Q/Q Growth
117.47% -126.72% 1,822.80% -247.03% 175.31% -85.77% -1,565.44% 132.07% 81.99% -102.51% 4,037.40%
Net Income Q/Q Growth
107.84% -198.52% 720.02% -556.36% 142.64% -120.74% -1,539.96% 107.98% 205.56% -105.26% 2,009.91%
EPS Q/Q Growth
0.00% 19.63% -50.76% 0.00% 0.00% -136.07% -68.18% 372.97% -217.82% 123.95% 284.21%
Operating Cash Flow Q/Q Growth
250.65% 32.64% -192.87% 204.71% -860.70% 113.27% -178.22% 56.75% 31.46% 233.06% -125.59%
Free Cash Flow Firm Q/Q Growth
-71.31% -3.59% 107.30% -765.21% 17.77% 10.21% -32.71% 88.59% 212.83% -144.19% 205.47%
Invested Capital Q/Q Growth
1.77% 1.60% 0.30% 23.64% 2.85% -2.66% 1.79% 2.37% -2.08% -0.64% 1.41%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
41.67% -33.60% 78.01% -304.48% 54.99% 17.11% 0.00% 32.37% 53.85% -9.01% 52.76%
EBIT Margin
44.10% -41.94% 77.62% -309.31% 53.46% 14.50% 0.00% 33.16% 53.52% -4.59% 54.02%
Profit (Net Income) Margin
30.80% -75.61% 71.95% -190.90% 35.60% -14.80% 0.00% 13.46% 36.48% -4.59% 37.43%
Tax Burden Percent
100.00% 100.00% 100.00% 82.35% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
69.85% 180.28% 92.69% 74.95% 66.60% -102.07% 114.22% 40.60% 68.16% 100.00% 69.30%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
6.14% -0.92% 8.82% -39.15% 13.12% 2.35% 0.00% 2.67% 4.60% -0.25% 8.35%
ROIC Less NNEP Spread (ROIC-NNEP)
4.66% -2.91% 6.79% -40.77% 10.87% 0.37% 0.00% 0.91% 2.91% -0.31% 6.76%
Return on Net Nonoperating Assets (RNNOA)
6.47% -4.07% 3.91% -29.23% 7.84% 0.26% 0.00% 0.81% 2.64% -0.28% 6.28%
Return on Equity (ROE)
12.60% -4.99% 12.73% -68.38% 20.97% 2.61% 0.00% 3.48% 7.24% -0.53% 14.63%
Cash Return on Invested Capital (CROIC)
-62.72% -72.04% -12.75% -10.79% -11.60% -11.52% -23.72% -5.53% -3.23% -5.11% 2.92%
Operating Return on Assets (OROA)
4.98% -1.05% 8.54% -72.51% 12.88% 3.27% 0.00% 2.61% 4.51% -0.35% 8.21%
Return on Assets (ROA)
3.48% -1.90% 7.92% -44.75% 8.58% -3.34% 0.00% 1.06% 3.07% -0.35% 5.69%
Return on Common Equity (ROCE)
12.60% -4.99% 12.73% -68.38% 20.97% 2.61% 0.00% 3.48% 7.24% -0.53% 14.63%
Return on Equity Simple (ROE_SIMPLE)
-2.34% -23.72% -15.36% 0.00% 23.49% 16.89% -1.75% 0.00% -10.88% -10.36% 7.52%
Net Operating Profit after Tax (NOPAT)
5.11 -1.37 24 -10 7.62 0.89 -13 4.20 7.64 -0.19 7.56
NOPAT Margin
44.10% -29.36% 77.62% -162.28% 53.46% 10.15% 0.00% 33.16% 53.52% -3.22% 54.02%
Net Nonoperating Expense Percent (NNEP)
1.48% 2.00% 2.03% 1.62% 2.25% 1.98% 7.18% 1.76% 1.69% 0.06% 1.59%
SG&A Expenses to Revenue
12.29% 32.75% 4.99% 38.27% 7.21% 13.46% 0.00% 12.76% 6.79% 17.04% 7.71%
Operating Expenses to Revenue
55.90% 141.94% 22.38% 409.31% 46.54% 85.50% 0.00% 66.84% 46.48% 104.59% 45.98%
Earnings before Interest and Taxes (EBIT)
5.11 -1.95 24 -19 7.62 1.28 -19 4.20 7.64 -0.27 7.56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4.83 -1.56 24 -19 7.84 1.51 -19 4.10 7.69 -0.54 7.38
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.56 0.55 0.59 0.61 0.63 0.69 0.65 0.60 0.57 0.50 0.52
Price to Tangible Book Value (P/TBV)
0.56 0.55 0.59 0.61 0.63 0.69 0.65 0.60 0.57 0.50 0.52
Price to Revenue (P/Rev)
3.40 14.74 3.48 1.53 1.54 1.76 3.56 3.94 3.39 3.31 1.75
Price to Earnings (P/E)
0.00 0.00 0.00 2.64 2.68 4.06 0.00 0.00 0.00 0.00 6.93
Dividend Yield
0.00% 0.00% 2.89% 2.75% 2.59% 5.07% 5.41% 5.75% 6.20% 0.00% 0.17%
Earnings Yield
0.00% 0.00% 0.00% 37.81% 37.37% 24.62% 0.00% 0.00% 0.00% 0.00% 14.44%
Enterprise Value to Invested Capital (EV/IC)
0.67 0.63 0.70 0.56 0.78 0.80 0.80 0.79 0.78 0.74 0.75
Enterprise Value to Revenue (EV/Rev)
6.28 26.04 6.38 2.60 3.58 3.84 8.36 10.02 9.01 9.62 4.89
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 4.44 5.88 7.04 261.28 0.00 0.00 0.00 12.30
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 4.50 6.04 7.22 1,132.98 0.00 0.00 0.00 11.99
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 4.50 6.20 8.86 0.00 0.00 0.00 0.00 19.30
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 23.34 57.79 10.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25.92
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.56 0.55 0.55 0.85 0.87 0.86 0.93 0.92 0.94 0.95 0.93
Long-Term Debt to Equity
0.56 0.55 0.55 0.00 0.00 0.00 0.93 0.00 0.00 0.00 0.93
Financial Leverage
1.39 1.40 0.58 0.72 0.72 0.71 0.74 0.88 0.91 0.91 0.93
Leverage Ratio
2.94 2.99 1.63 1.77 1.75 1.75 1.78 1.93 1.94 1.94 1.96
Compound Leverage Factor
2.05 5.39 1.51 1.32 1.17 -1.79 2.03 0.78 1.33 1.94 1.36
Debt to Total Capital
35.88% 35.39% 35.61% 45.86% 46.56% 46.37% 48.07% 47.96% 48.49% 48.83% 48.21%
Short-Term Debt to Total Capital
0.00% 0.04% 0.00% 45.83% 46.54% 46.36% 0.00% 47.91% 48.44% 48.78% 0.03%
Long-Term Debt to Total Capital
35.88% 35.35% 35.61% 0.03% 0.02% 0.02% 48.07% 0.04% 0.04% 0.04% 48.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
64.12% 64.61% 64.39% 54.14% 53.44% 53.63% 51.93% 52.04% 51.51% 51.17% 51.79%
Debt to EBITDA
-18.99 -2.29 -4.64 3.65 3.52 4.07 157.95 -27.94 -35.66 -23.83 7.89
Net Debt to EBITDA
-16.25 -1.77 -4.16 1.83 3.34 3.81 150.03 -27.94 -35.66 -23.83 7.89
Long-Term Debt to EBITDA
-18.99 -2.29 -4.64 0.00 0.00 0.00 157.95 -0.03 -0.03 -0.02 7.88
Debt to NOPAT
-34.11 -3.30 -6.11 3.70 3.71 5.12 -75.57 -37.74 -12.36 -13.16 12.38
Net Debt to NOPAT
-29.18 -2.55 -5.47 1.86 3.52 4.80 -71.79 -37.74 -12.36 -13.16 12.38
Long-Term Debt to NOPAT
-34.11 -3.30 -6.11 0.00 0.00 0.00 -75.57 -0.03 -0.01 -0.01 12.37
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-105 -109 7.96 -75 -62 -57 -75 -8.60 9.70 -4.29 4.52
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 -11.39 0.00 0.00 0.00 0.00 0.00 -1.86 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.00 0.00 1.17 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 1.32 0.00 0.00 0.00 0.00 0.00 1.17 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.11 0.03 0.11 0.23 0.24 0.23 0.10 0.08 0.08 0.08 0.15
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
235 239 239 296 305 296 302 309 302 301 305
Invested Capital Turnover
0.14 0.03 0.11 0.24 0.25 0.23 0.11 0.08 0.09 0.08 0.15
Increase / (Decrease) in Invested Capital
110 108 16 65 70 58 62 13 -2.06 4.10 3.03
Enterprise Value (EV)
157 151 168 165 237 238 240 244 235 224 229
Market Capitalization
85 85 92 97 102 109 102 96 88 77 82
Book Value per Share
$72.71 $74.87 $76.35 $78.57 $80.59 $78.72 $77.67 $79.78 $77.85 $77.96 $81.68
Tangible Book Value per Share
$72.71 $74.87 $76.35 $78.57 $80.59 $78.72 $77.67 $79.78 $77.85 $77.96 $81.68
Total Capital
235 239 239 296 305 296 302 309 302 301 305
Total Debt
84 85 85 136 142 137 145 148 147 147 147
Total Long-Term Debt
84 84 85 0.09 0.05 0.05 145 0.13 0.13 0.13 147
Net Debt
72 65 76 68 135 129 138 148 147 147 147
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
1.54 2.15 1.72 1.78 2.55 2.20 8.27 2.49 2.43 0.08 2.32
Net Nonoperating Obligations (NNO)
84 85 85 136 142 137 145 148 147 147 147
Total Depreciation and Amortization (D&A)
-0.28 0.39 0.12 0.30 0.22 0.23 -0.04 -0.10 0.05 -0.26 -0.18
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.29 $0.00 $1.22 ($0.44) ($0.74) $2.02 ($2.38) $0.57 $2.19
Adjusted Weighted Average Basic Shares Outstanding
2.07M 2.05M 2.02M 2.04M 2.02M 2.02M 2.02M 2.02M 2.00M 1.97M 1.93M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $1.22 ($0.44) ($0.74) $2.02 ($2.38) $0.57 $2.19
Adjusted Weighted Average Diluted Shares Outstanding
2.06M 2.02M 2.02M 2.04M 2.02M 2.02M 2.02M 2.02M 2.00M 1.97M 1.93M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.06M 2.02M 2.02M 2.02M 2.02M 2.02M 2.00M 2.00M 2.00M 1.93M 1.93M
Normalized Net Operating Profit after Tax (NOPAT)
3.58 -1.37 16 -10 5.33 0.89 -13 2.94 5.35 -0.19 5.29
Normalized NOPAT Margin
30.87% -29.36% 54.34% -162.28% 37.42% 10.15% 0.00% 23.21% 37.46% -3.22% 37.81%
Pre Tax Income Margin
30.80% -75.61% 71.95% -231.83% 35.60% -14.80% 0.00% 13.46% 36.48% -4.59% 37.43%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 -2.92 0.00 0.00 0.00 0.00 0.00 -0.12 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 -1.53 0.00 0.00 0.00 0.00 0.00 -0.08 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 -2.92 0.00 0.00 0.00 0.00 0.00 -0.12 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 -1.53 0.00 0.00 0.00 0.00 0.00 -0.08 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% -11.17% 7.20% 0.00% 20.61% -105.33% -18.18% 0.00% 0.00% 1.19%
Augmented Payout Ratio
-42.24% -8.32% -23.67% 13.66% 4.79% 20.73% -134.35% -23.22% -5.80% -25.90% 29.50%

Financials Breakdown Chart

Key Financial Trends

PhenixFIN (NYSE: PFX) has shown a sharp turnaround in the most recent quarter, but the longer-term picture remains volatile. For Q2 2026, the company posted a small net loss of $274,115 on the income statement, but the cash flow statement shows positive net income of $1.13 million and strong operating cash flow of $2.71 million. That gap suggests timing and non-cash items are still making earnings somewhat noisy. The balance sheet remains heavily asset-driven, with total assets of $305.6 million and equity of $153.8 million.

Over the last four years, PFX has had very inconsistent earnings and cash generation. Revenue has swung dramatically from quarter to quarter, largely because non-interest income and investment-related gains/losses are volatile. In the most recent two quarters, the business moved from a Q1 2026 loss to a Q2 2026 return to profitability on a cash basis, but the earlier periods show that this is not yet a stable earnings profile.

  • Operating cash flow improved materially in Q2 2026, rising to $2.71 million from a negative $2.04 million in Q1 2026.
  • Net income also improved sharply quarter over quarter, moving from a $4.77 million loss in Q1 2026 to a $1.13 million gain in Q2 2026 on the cash flow statement.
  • Leverage eased somewhat, with total liabilities declining to $151.8 million in Q2 2026 from $151.6 million in Q1 2026 and debt levels remaining broadly controlled versus the asset base.
  • Book equity held steady to slightly higher, increasing to $153.8 million in Q2 2026 from $155.8 million in Q1 2026, reflecting a relatively stable balance sheet.
  • Investment securities interest income remained strong, contributing $9.33 million in Q2 2026.
  • Q2 2026 revenue was supported mainly by net interest income, while non-interest income was negative due to investment losses, showing that results still depend heavily on market-related items.
  • The company’s equity base is large relative to its quarterly earnings power, which can help absorb volatility but also highlights limited consistency in profitability.
  • Q2 2026 reported net income on the income statement was still negative at $274,115, underscoring the difference between accounting earnings and cash flow results.
  • Interest expense remains meaningful, with $2.31 million of total interest expense in Q2 2026 and cash interest paid of $2.18 million, which pressures profitability.
  • Historically, quarterly results have been highly erratic, including large losses in Q3 2025 and Q4 2024, driven by swings in capital gains/losses and operating expenses.

Looking at the broader trend, PFX is not a steady compounding story yet. In 2024, the company alternated between strong profitable quarters and very weak ones, including a steep loss in Q4 2024. In 2025, performance remained uneven, with Q3 2025 especially weak on both revenue and earnings, followed by a better Q4 2025 and a mixed start to 2026. The main takeaway for retail investors is that PhenixFIN can generate solid quarters, but the business appears sensitive to investment performance, financing costs, and operating expense swings.

Overall, the latest quarter is encouraging on cash generation, but the multi-year record still points to a volatile financial profile. Investors will likely want to see whether Q2 2026 marks the beginning of a more consistent trend or just another short-lived rebound.

08/06/26 02:49 PM ETAI Generated. May Contain Errors.

PhenixFIN Financials - Frequently Asked Questions

According to the most recent income statement we have on file, PhenixFIN's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

PhenixFIN's net income appears to be on a downward trend, with a most recent value of -$15.89 million in 2025, falling from $13.32 million in 2021. The previous period was $21.92 million in 2024. Find out what analysts predict for PhenixFIN in the coming months.

Over the last 4 years, PhenixFIN's total revenue changed from $55.80 million in 2021 to $24.36 million in 2025, a change of -56.3%.

PhenixFIN's total liabilities were at $156.14 million at the end of 2025, a 9.6% increase from 2024, and a 59.3% increase since 2022.

In the past 3 years, PhenixFIN's cash and equivalents has ranged from $5.99 million in 2023 to $67.57 million in 2024, and is currently $7.29 million as of their latest financial filing in 2025.

Over the last 4 years, PhenixFIN's book value per share changed from 0.00 in 2021 to 79.78 in 2025, a change of 7,978.3%.



Financial statements for NYSE:PFX last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners